Office of the Chief Science Officer Mail Stop: 6502A Ottawa, Ontario K1A OK9 Canada July 31, 2014 Dr. Nick Vahanian BioProtection Systems Corporation, Iowa State University Research Park Ames, Iowa, 50010 USA Dear Dr. Vahanian, Re: Amendment to the...Sole License Agreement • November 10th, 2014 • Newlink Genetics Corp • Pharmaceutical preparations
Canada and BioProtection Systems Corporation (BPSC) have executed a License Agreement dated May 04, 2010, under which Canada granted a license to BPS to commercialize the technology developed by Canada known as the recombinant vesicular stomatitis virus vaccine for viral hemorrhagic fevers (rVSV). For greater clarity, the Parties hereby agree to amend the License Agreement to define the scope of the “Licensed Rights” as follows:
